Imatinib in active diffuse cutaneous systemic sclerosis: Results of a six-month, randomized, double-blind, placebo-controlled, proof-of-concept pilot study at a single center. (Q54573262)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Imatinib in active diffuse cutaneous systemic sclerosis: Results of a six-month, randomized, double-blind, placebo-controlled, proof-of-concept pilot study at a single center. |
scientific article |
Statements
Imatinib in active diffuse cutaneous systemic sclerosis: Results of a six-month, randomized, double-blind, placebo-controlled, proof-of-concept pilot study at a single center. (English)
Donna McBain
Lisa Petrlich
Sharon Watson
Louise Vanderhoek
Faye de Leon
Shannon Seney
Kelly Summers
1 November 2011
63
11
3547-3551
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference